Bank Of New York Mellon Corp Rigel Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $378,312 - $6.72 Million	564,645 New	564,645 $846,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $49,613 - $550,256	45,103 Added 8.61%	568,712 $671,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $20,108 - $95,738	-30,012 Reduced 5.42%	523,609 $592,000
Q1 2022 May 11, 2022	BUY	$2.22 - $3.45 $3,212 - $4,992	1,447 Added 0.26%	553,621 $1.66 Million
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $23,975 - $36,267	10,159 Added 1.87%	552,174 $1.46 Million
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $105,280 - $135,360	30,080 Added 5.88%	542,015 $1.97 Million
Q2 2021 Aug 11, 2021	SELL	$3.09 - $4.54 $331,328 - $486,806	-107,226 Reduced 17.32%	511,935 $2.22 Million
Q1 2021 May 13, 2021	SELL	$3.35 - $4.93 $170,163 - $250,419	-50,795 Reduced 7.58%	619,161 $2.12 Million
Q4 2020 Feb 09, 2021	SELL	$2.35 - $3.74 $9,811 - $15,614	-4,175 Reduced 0.62%	669,956 $2.34 Million
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $20,203 - $46,875	-11,350 Reduced 1.66%	674,131 $1.62 Million
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.05 $4,867 - $7,076	-3,452 Reduced 0.5%	685,481 $1.25 Million
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $19,073 - $28,968	11,921 Added 1.76%	688,933 $1.47 Million
Q3 2019 Nov 07, 2019	SELL	$1.63 - $2.62 $61,165 - $98,315	-37,525 Reduced 5.25%	677,012 $1.27 Million
Q2 2019 Aug 12, 2019	SELL	$2.02 - $2.61 $3,139 - $4,055	-1,554 Reduced 0.22%	714,537 $1.87 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $1,218 - $1,613	609 Added 0.09%	716,091 $1.84 Million
Q4 2018 Feb 11, 2019	BUY	$2.08 - $3.36 $50,826 - $82,104	24,436 Added 3.54%	715,482 $1.65 Million
Q3 2018 Nov 09, 2018	SELL	$2.6 - $3.59 $143,717 - $198,440	-55,276 Reduced 7.41%	691,046 $0
Q2 2018 Aug 06, 2018	SELL	$2.83 - $4.11 $25,860 - $37,557	-9,138 Reduced 1.21%	746,322 $2.11 Million
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $22,999 - $29,496	6,497 Added 0.87%	755,460 $2.67 Million
Q4 2017 Feb 09, 2018	BUY	$3.23 - $4.3 $2.42 Million - $3.22 Million	748,963	748,963 $2.91 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account